CCO Infectious Disease Podcast

Long-Acting ART: Cabotegravir Plus Rilpivirine

Episode Summary

Listen to Ian Frank, MD, discuss long-acting HIV treatment with cabotegravir plus rilpivirine for treatment-experienced PWH, including efficacy data, initiation strategies, virologic failure data, and safety information.

Episode Notes

In this episode, Ian Frank, MD, discusses long-acting HIV treatment with cabotegravir plus rilpivirine for people with HIV, including:

• Efficacy data with every-8-week dosing
• Real-world use in people with viremia 
• Initiation and continuation strategies
• Virologic failure data
• Safety information

Presenter:

Ian Frank, MD

Associate Chief

Division of Infectious Diseases

Professor of Medicine

University of Pennsylvania

Philadelphia, Pennsylvania

To download the slides: https://bit.ly/3HX1GGn

To view the full online program: https://bit.ly/3ZjSFhg